2031年兽用疫苗市场规模、份额、增长和趋势分析及预测

  • Report Code : TIPRE00003539
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 299
立即购买

兽用疫苗市场规模预计将从2024年的91.3亿美元增至2031年的136.7亿美元。预计2025年至2031年期间,该市场的复合年增长率将达到6.0%。兽用疫苗产品的技术进步有望在未来几年为市场带来新的趋势。

 

兽用疫苗市场分析

市场增长的驱动力在于宠物收养率的提高、动物健康意识的增强以及兽医护理支出的增加。人畜共患疾病发病率的上升也对市场产生了影响,这凸显了疫苗接种在动物和公共卫生中的重要性。此外,区域性生产设施可确保更快的配送速度并降低对进口的依赖,尤其是在印度、巴西和非洲等发展中地区。政府和机构通过激励措施促进本地生产,例如印度的“印度制造”计划,该计划促进了兽药产品的本地生产。这些投资为提高效率、创新和增加疫苗供应提供了机会。总体而言,在技术进步和对动物预防性医疗保健日益关注的推动下,兽用疫苗市场有望持续扩张。

 

兽用疫苗市场概况

伴侣动物拥有量的增加提高了人们对宠物健康和预防保健的认识,最终增加了对保护宠物免受传染病侵害的疫苗的需求。根据美国宠物产品协会 (APPA) 的数据,美国家庭拥有宠物的比例从 2019 年的 67% 上升到 2022 年的 70%。这一趋势在发达国家和印度、中国等新兴经济体中普遍存在。由于城市化和可支配收入的提高,这些经济体的宠物收养率有所上升。2022 年 9 月,世界卫生组织 (WHO) 启动了针对狂犬病等人畜共患病的疫苗接种运动,这些疾病可从动物传播给人类。世卫组织提倡消除狂犬病的运动,其中包括大规模为犬类接种疫苗作为预防措施。这些举措鼓励发达地区和发展中地区接受疫苗接种。总而言之,宠物拥有量和伴侣动物数量的增加推动了兽用疫苗市场的增长。这一趋势的推动因素包括社会对宠物态度的转变、可支配收入的增加以及全球控制人畜共患疾病的举措。随着宠物保健行业的不断发展,对有效疫苗的需求预计将会增长。

 

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

兽用疫苗市场:

Veterinary Vaccines Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

 

兽用疫苗市场驱动因素和机遇

 

动物健康意识不断提高

过去十年,人们对动物健康的认识发生了转变,动物健康不仅是保障动物福祉的手段,也是公共卫生、粮食安全和经济稳定的关键因素。联合国粮食及农业组织 (FAO) 强调,健康的牲畜对可持续的粮食系统至关重要,并推动采用疫苗来预防口蹄疫、布鲁氏菌病和禽流感。宠物主人也越来越意识到预防性医疗保健(例如接种疫苗)的重要性,以确保他们的伴侣动物能够活得更长寿、更健康。根据美国兽医协会 (AVMA) 2022 年的一项调查,超过 80% 的美国宠物主人表示愿意为他们的宠物投资定期接种疫苗和体检,这凸显了主动性动物医疗保健日益受到重视。

通过数字平台、兽医组织和公共宣传活动,动物健康信息日益普及,使宠物主人和养殖户能够了解可预防疾病的风险,包括狂犬病和钩端螺旋体病等人畜共患疾病,这些疾病可以通过动物传播给人类。世界卫生组织和世界动物卫生组织(WOAH)等组织已发起全球宣传活动,强调疫苗接种在控制人畜共患疾病中的作用。世界卫生组织的《2030年终结犬类狂犬病导致人类死亡的全球战略计划》推动了大规模推广疫苗接种的举措。兽医作为预防保健的倡导者,其作用促进了人们意识的提升。兽医在教育宠物主人和养殖户疫苗接种时间表、免疫接种的益处以及忽视预防保健的风险方面发挥着积极作用。兽医学的进步,例如联合疫苗的开发,简化了疫苗接种程序并提高了动物主人的依从性,进一步提高了人们的意识。

 

扩大生产设施以创造增长机会

生产工厂的增加为兽用疫苗市场带来了巨大的增长前景。它解决了一些紧迫的问题,包括生产可扩展性、降低成本以及使疫苗在区域内更容易获得。随着宠物拥有量增加、畜牧业需求和国际疾病预防项目推动兽用疫苗需求飙升,生产商正在投资新建工厂并翻新旧工厂以提高产能。2024年3月,硕腾公司宣布收购位于墨尔本一座占地21英亩的生产设施,以扩大其现有业务并提升未来生产和研发羊、牛、犬、猫和马疫苗的能力。勃林格殷格翰公司在2021年投资超过2.0901亿美元,用于扩建其位于法国里昂的兽用疫苗生产工厂,用于重组疫苗等尖端疫苗技术。这些扩张增加了供应以满足需求,并通过规模经济降低了生产成本。

 

兽用疫苗市场报告细分分析

有助于得出兽医疫苗市场分析的关键部分是技术、动物类型、给药途径、最终用户和地理位置。

  • 根据技术,兽用疫苗市场可细分为减毒活疫苗、灭活疫苗、重组疫苗、类毒素疫苗等。2024年,减毒活疫苗占据兽用疫苗市场最大份额,预计在2025年至2031年期间将实现显著的复合年增长率。
  • 根据动物类型,市场分为伴侣动物、牲畜和 家禽。2024年,牲畜和家禽类疫苗占据兽用疫苗市场的最大份额。伴侣动物类疫苗进一步分为犬、猫、马和其他动物。家畜和家禽类疫苗又分为鸡、牛和其他动物。2024年,牲畜和家禽类疫苗占据兽用疫苗市场的最大份额。
  • 根据给药途径,兽用疫苗市场分为肌肉注射、皮下注射和其他途径。2024年,肌肉注射占据了兽用疫苗市场的大部分份额,预计在2025年至2031年期间将实现显著的复合年增长率。
  • 从最终用户角度来看,兽用疫苗市场可细分为兽医院、兽诊所和其他。2024年,兽医院占据了兽用疫苗市场的最大份额,预计在2025年至2031年期间将实现显著的复合年增长率。

 

兽用疫苗市场份额地域分析

兽用疫苗市场报告的地理范围主要分为五大区域:北美、欧洲、亚太地区、中东和非洲、南美和中美。预计北美将在 2024 年占据市场主导地位。市场增长的因素包括市场参与者推出的兽用疫苗越来越多、政府对提供具有成本效益的医疗服务的支持不断增加、兽用疫苗参与者为增强服务而不断推出的战略发展、以及不断发展的医疗保健行业需要基于真实世界数据的框架和指南作为其商业模式的基础。牲畜群体为消费者提供不同的产品和服务,包括肉、奶、蛋、纤维和挽力。在美国,牲畜、伴侣动物和其他动物的病毒感染是动物健康的一个关键方面。感染动物的病毒传播速度更快。因此,对动物进行此类病毒的免疫接种对该国的动物保健至关重要。口蹄疫是一种高度传染性的病毒性疾病,主要感染偶蹄动物,例如牛、猪、绵羊和山羊。尽管美国数十年来一直没有出现口蹄疫疫情,但世界其他地区,尤其是在国际贸易和动物运输密切的地区,疫情的爆发仍构成持续的风险。美国政府和农业部门已做好疫情爆发时迅速应对的准备,而疫苗对于疫情的管理和控制至关重要。据美国农业部称,动植物卫生检验局 (APHIS) 在 2022 年从私营企业投资约 4200 万美元用于口蹄疫疫苗抗原浓缩物,并在 2023 年额外投资 3000 万美元。

宠物拥有量的不断增长推动了美国伴侣动物疫苗的需求。根据美国宠物产品协会2023-2024年的调查,66%的美国家庭(相当于8690万户家庭)拥有宠物。此外,研发活动的增加预计将进一步推动兽用疫苗市场的增长。

 

 

兽用疫苗市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响兽用疫苗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲兽用疫苗市场的细分市场和地域分布。

Veterinary Vaccines Market
  • 获取兽医疫苗市场的区域特定数据

兽用疫苗市场报告范围

报告属性细节
2024年的市场规模91.3亿美元
2031年的市场规模136.7亿美元
全球复合年增长率(2025-2031)6.0%
史料2021-2023
预测期2025-2031
涵盖的领域按技术
  • 减毒活疫苗
  • 灭活疫苗
  • 重组疫苗
  • 类毒素疫苗
按动物类型
  • 伴侣
  • 牲畜和家禽
按给药途径
  • 肌肉注射
  • 皮下
按最终用户
  • 兽医院
  • 兽医诊所
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 勃林格殷格翰国际有限公司
  • 硕腾公司
  • 默克公司
  • 维克公司
  • 生物真空有限公司
  • Neogen 公司
  • 礼来动物保健公司
  • 希普拉公司
  • Ceva Sante Animale
  • 海丝特生物科学有限公司

 

兽用疫苗市场参与者密度:了解其对业务动态的影响

兽用疫苗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的转变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在兽医疫苗市场运营的主要公司有:

  1. 勃林格殷格翰国际有限公司
  2. 硕腾公司
  3. 默克公司
  4. 维克公司
  5. 生物真空有限公司
  6. Neogen 公司

免责声明以上列出的公司没有按照任何特定顺序排列。


Veterinary Vaccines Market

 

  • 获取兽医疫苗市场主要参与者概览

 

兽用疫苗市场新闻及最新发展

兽用疫苗市场评估是通过收集一手和二手研究后的定性和定量数据进行的,这些数据包括重要的企业出版物、协会数据和数据库。以下列出了市场的一些关键发展:

  • 硕腾公司宣布,美国农业部 (USDA) 兽医生物制品中心 (CVB) 已向该公司颁发了其禽流感疫苗 H5N2 亚型灭活病毒的有条件许可。该疫苗标称可用于鸡。该有条件许可是基于安全性、纯度以及基于血清学数据的合理预期疗效的证明而授予的。(来源:硕腾公司网站,2025 年 2 月)
  • 诗华动物保健(Ceva)——全球第五大动物保健企业,业务遍及110个国家/地区,近日公布了其对欧洲疫苗生产的最新投资,在匈牙利新建了一家工厂,以扩大诗华疫苗(Ceva Phylaxia)的产能。(来源:诗华,公司网站,2024年11月)

 

兽医疫苗市场报告覆盖范围和交付成果

《兽用疫苗市场规模和预测(2021-2031)》报告对以下领域进行了详细的市场分析:

  • 兽用疫苗市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 兽用疫苗市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 兽医疫苗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及兽用疫苗市场的最新发展
  • 详细的公司简介
  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
veterinary-vaccines-market-report-deliverables-img1
veterinary-vaccines-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What would be the estimated value of the veterinary vaccines Market by 2031?

The market value is expected to reach US$ 13.67.00 billion by 2031.

Which region dominated the veterinary vaccines Market in 2024?

North America dominated the market in 2024.

What are the factors driving the veterinary vaccines Market growth?

Rising pet ownership and companion animal population and growing awareness of animal health are significant factors fueling the market growth.

What are the future trends in the veterinary vaccines Market?

Technological advancements in veterinary vaccine products are expected to emerge as a prime trend in the market in the coming years.

Which are the leading players operating in the veterinary vaccines Market?

Boehringer Ingelheim International GmbH, Zoetis Inc, Merck & Co Inc, Virbac SA, Biovac LTD, Neogen Corp, Elanco Animal Health Inc, HIPRA SA, Ceva Santé Animale, and Hester Biosciences Ltd are among the key players in the market.

What is the expected CAGR of the veterinary vaccines Market?

The market is expected to register a CAGR of 6.0% during 2025–2031.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Veterinary Vaccines Market

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Merck & Co Inc
  • Virbac SA
  • Biovac LTD
  •  Neogen Corp
  •  Elanco Animal Health Inc
  •  HIPRA SA
  •  Ceva Santé Animale
  • Hester Biosciences Ltd
veterinary-vaccines-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.